For example, in NSCLC, tRF-Leu-CAG could suppress the proliferation of NSCLC cells and inhibit G0/G1 cell-cycle progression through targeting AURKA (Figure 3A) 44. The gene discussed is AURKA; the disease is non-small cell lung carcinoma.